Multiplex Assay Kit for Von Hippel Lindau Tumor Suppressor (vHL) ,etc. by CBA (Cytometric Bead Array)

HRCA1; RCA1; VHL1; Von Hippel-Lindau Syndrome

Specificity

This assay has high sensitivity and excellent specificity for detection of Von Hippel Lindau Tumor Suppressor (vHL) ,etc. by CBA (Cytometric Bead Array).
No significant cross-reactivity or interference between Von Hippel Lindau Tumor Suppressor (vHL) ,etc. by CBA (Cytometric Bead Array) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Von Hippel Lindau Tumor Suppressor (vHL) ,etc. by CBA (Cytometric Bead Array) and the recovery rates were calculated by comparing the measured value to the expected amount of Von Hippel Lindau Tumor Suppressor (vHL) ,etc. by CBA (Cytometric Bead Array) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 81-96 91
EDTA plasma(n=5) 96-104 101
heparin plasma(n=5) 81-96 89

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Von Hippel Lindau Tumor Suppressor (vHL) ,etc. by CBA (Cytometric Bead Array) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Von Hippel Lindau Tumor Suppressor (vHL) ,etc. by CBA (Cytometric Bead Array) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Von Hippel Lindau Tumor Suppressor (vHL) ,etc. by CBA (Cytometric Bead Array) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 85-103% 80-101% 80-104% 90-97%
EDTA plasma(n=5) 78-103% 88-95% 83-91% 91-105%
heparin plasma(n=5) 78-98% 99-105% 81-105% 92-99%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity

Assay procedure summary

1. Add 200μL analysis buffer solution to each well of the plate for pre-wetting;
2. Preparation of standards, reagents and samples before the experiment;
3. Add 100μL standard or sample to each well, add 10μL magnetic beads, and incubate 120 minutes protect from light at 25°C on shaker;
4. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60 minutes protect from light at 25°C on shaker;
5. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent B, and incubate 30 minutes protect from light at 25°C on shaker;
6. Wash plate once on magnetic frame;
7. Add 100μL sheath fluid, swirl for 10 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Catalog No. Related products for research use of Rattus norvegicus (Rat) Organism species Applications (RESEARCH USE ONLY!)
RPJ769Ra01 Recombinant Von Hippel Lindau Tumor Suppressor (vHL) Positive Control; Immunogen; SDS-PAGE; WB.
PAJ769Ra01 Polyclonal Antibody to Von Hippel Lindau Tumor Suppressor (vHL) WB; IHC
MAJ769Ra22 Monoclonal Antibody to Von Hippel Lindau Tumor Suppressor (vHL) IHC
MAJ769Ra21 Monoclonal Antibody to Von Hippel Lindau Tumor Suppressor (vHL) IHC
SEJ769Ra ELISA Kit for Von Hippel Lindau Tumor Suppressor (vHL) Enzyme-linked immunosorbent assay for Antigen Detection.
CMJ769Ra Multiplex Assay Kit for Von Hippel Lindau Tumor Suppressor (vHL) ,etc. by CBA (Cytometric Bead Array) FLIA Kit for Antigen Detection.
LMJ769Ra Multiplex Assay Kit for Von Hippel Lindau Tumor Suppressor (vHL) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.